Skip to main content

Table1 Clinical characteristics of PTB patients in the training set and validation set

From: Clinical characteristics and predictive model of pulmonary tuberculosis patients with pulmonary fungal coinfection

Variable

Training set(n = 214)

Validation set(n = 72)

p

Pulmonary fungal infection [n(%)]

Yes

102 (47.7)

41 (56.9)

0.173

No

112 (52.3)

31 (43.1)

 

Age [n(%)]

 > 65 years old

54 (25.2)

16 (22.2)

0.607

 ≤ 65 years old

160 (74.8)

56 (77.8)

 

Gender [n(%)]

Male

164 (76.6)

48 (66.7)

0.095

Female

50 (23.4)

24 (33.3)

 

Address [n(%)]

North

206 (96.3)

71 (98.6)

0.458

South

8 (3.7)

1 (1.4)

 

Smoke [n(%)]

Yes

89 (41.6)

29 (40.3)

0.845

No

125 (58.4)

43 (59.7)

 

Drink [n(%)]

Yes

67 (31.3)

22 (30.6)

 

No

147 (68.7)

50 (69.4)

0.905

Category [n(%)]

Initial

155 (72.4)

16 (22.2)

0.372

Recurrent

59 (27.6)

56 (77.8)

 

Drug resistance [n(%)]

No drug resistance

178 (83.2)

59 (81.9)

0.563

Single drug resistance

17 (7.9)

4 (5.6)

 

Other drug resistance

19 (8.9)

9 (12.5)

 

Illness course [n(%)]

 ≤ 1 year

104 (48.6)

33 (45.8)

0.062

 > 1 year, ≤ 5 years

59 (27.6)

13 (18.1)

 

 > 5 years, ≤ 10 years

19 (8.9)

14 (19.4)

 

 > 10 years

32 (15.0)

12 (16.7)

 

Pulmonary cavitation [n(%)]

Yes

126 (58.9)

34 (7.2)

0.085

No

88 (41.1)

38 (52.8)

 

Pleural effusion [n(%)]

Yes

82 (38.3)

25 (34.7)

0.585

No

132 (61.7)

47 (65.3)

 

Regular anti-tuberculosis [n(%)]

Yes

121 (56.5)

42 (58.3)

0.791

No

93 (43.5)

30 (41.7)

 

Broad-spectrum antibiotics were used for at least 1 week [n(%)]

Yes

89 (41.6)

35 (48.6)

0.298

No

125 (58.4)

37 (51.4)

 

Glucocorticoid were used for at least 2 weeks [n(%)]

Yes

31 (14.5)

8 (11.1)

0.470

No

183 (85.5)

64 (88.9)

 

Chemotherapy or immunosuppressants [n(%)]

Yes

10 (4.7)

1 (1.4)

0.210

No

204(95.3)

71(98.6)

 

Invasive operation [n(%)]

Yes

150 (70.1)

48 (66.7)

0.586

No

64 (29.9)

24 (33.3)

 

Surgery [n(%)]

Yes

81 (37.9)

27 (37.5)

 

No

133 (62.1)

45 (62.5)

0.958

Bacterial pneumonia [n(%)]

Yes

27 (12.6)

12 (16.7)

0.386

No

187 (87.4)

60 (83.3)

 

Chronic bronchitis/ COPD/Bronchiectasis/Asthma [n(%)]

Yes

28 (13.1)

8 (11.1)

0.662

No

186 (86.9)

64 (88.9)

 

Silicosis [n(%)]

Yes

3 (1.4)

4 (5.6)

0.070

No

211 (98.6)

68 (94.4)

 

Interstitial lung disease [n(%)]

Yes

7 (3.3)

2 (2.8)

1.000

No

207 (96.7)

70 (97.2)

 

Hepatic injury [n(%)]

Yes

68 (31.8)

18 (25.0)

 

No

146 (68.2)

54 (75.0)

0.278

Renal inadequacy [n(%)]

Yes

15 (7.0)

1 (1.4)

0.081

No

199 (93.0)

71 (98.6)

 

Tumor / Hematological disease [n(%)]

Yes

12 (5.6)

5 (6.9)

0.773

No

202 (94.4)

67 (93.1)

 

Hypoproteinemia [n(%)]

Yes

77 (36.0)

28 (38.9)

0.658

No

137 (64.0)

44 (61.1)

 

Anemia [n(%)]

Yes

62 (29.0)

21 (29.2)

0.975

No

152 (71.0)

51 (70.8)

 

Diabetes [n(%)]

Yes

49 (22.9)

19 (26.4)

0.547

No

165 (77.1)

53 (73.6)

Â